| Literature DB >> 25042074 |
Zdenka O Kyjovska1, Nicklas R Jacobsen, Anne T Saber, Stefan Bengtson, Petra Jackson, Håkan Wallin, Ulla Vogel.
Abstract
We previously observed genotoxic effects of carbon black nanoparticles at low doses relative to the Danish Occupational Exposure Limit (3.5 mg/m(3)). Furthermore, DNA damage occurred inEntities:
Keywords: comet assay; genotoxicity; lung inflammation; nanoparticles
Mesh:
Substances:
Year: 2014 PMID: 25042074 PMCID: PMC4312987 DOI: 10.1002/em.21888
Source DB: PubMed Journal: Environ Mol Mutagen ISSN: 0893-6692 Impact factor: 3.216
Figure 1DLS analysis of instillation medium.
Summary of Total Cell Counts from BAL Fluid and Cells Distribution by Cells Types 1, 3, and 28 Days Postexposure to NPCB and Vehicle (Particle Exposed Groups n = 8, Vehicle Group n = 12)
| Dose | Vehicle (H2O) | Printex 90 | ||||
|---|---|---|---|---|---|---|
| 0 µg | 0.67 µg | 2 µg | 6 µg | 162 µg | ||
| 1 Day | Neutrophils | 0.7 ± 0.4 | 8.8 ± 2.0*** | 5.4 ± 0.8*** | 5.2 ± 1.4** | 128.7 ± 14.0*** |
| Macrophages | 67.7 ± 5.2 | 67.3 ± 6.5 | 55.5 ± 5.0 | 49.2 ± 3.0 | 35.5 ± 4.1*** | |
| Eosinophils | 2.0 ± 1.1 | 2.9 ± 1.3 | 2.2 ± 0.8 | 0.8 ± 0.2 | 5.5 ± 3.1 | |
| Lymphocytes | 1.1± 0.5 | 0.3 ± 0.2 | 0.7 ± 0.2 | 0.5 ± 0.2 | 0.0 ± 0.0* | |
| Epithelial cells | 11.1 ± 1.2 | 9.3 ± 0.7 | 12.0 ± 2.3 | 14.1 ± 2.0 | 21.7 ± 5.0 | |
| Total BAL cells | 70.0 ± 9.6 | 88.8 ± 8.9 | 75.8 ± 6.2 | 69.8 ± 3.6 | 191.4 ± 20.0*** | |
| 3 days | Neutrophils | 1.9± 0.9 | 3.7 ± 1.6** | 0.9 ± 0.3 | 0.2 ± 0.1 | 132.4 ± 4.7*** |
| Macrophages | 56.7 ± 9.1 | 69.3 ± 6.6 | 51.2 ± 4.9 | 44.7 ± 4.3 | 58.8 ± 6.2 | |
| Eosinophils | 0.2 ± 0.1 | 20.2 ± 10.1*** | 2.6 ± 1.0** | 0.7 ± 0.2 | 2.0 ± 1.5 | |
| Lymphocytes | 0.2 ± 0.1 | 1.3 ± 0.3** | 0.4 ± 0.2 | 0.5 ± 0.3 | 0.6 ± 0.3 | |
| Epithelial cells | 11.4 ± 2.7 | 9.7 ± 1.4 | 10.6 ± 1.3 | 9.6 ± 1.8 | 14.9 ± 2.5 | |
| Total BAL cells | 70.4 ± 11.1 | 104.0 ± 14.3 | 65.7 ± 5.3 | 55.6 ± 6.0 | 207.4 ± 17.0*** | |
| 28 days | Neutrophils | 1.5 ± 0.8 | 0.2 ± 0.1 | 0.9 ± 0.3 | 0.4 ± 0.2 | 20.8 ± 3.6*** |
| Macrophages | 53.2± 7.6 | 48.0 ± 3.7 | 37.6 ± 5.3 | 35.6 ± 4.8 | 106.1 ± 10.4** | |
| Eosinophils | 1.3 ± 0.9 | 0.6 ± 0.3 | 2.1 ± 1.5 | 0.0 ± 0.0 | 0.1 ± 0.1 | |
| Lymphocytes | 0.4 ± 0.2 | 0.6 ± 0.3 | 1.5 ± 0.6 | 0.8 ± 0.2 | 29.2 ± 3.7*** | |
| Epithelial cells | 14.9 ± 2.2 | 7.0 ± 0.9 | 9.5 ± 1.9 | 8.1 ± 1.4 | 15.4 ± 3.9 | |
| Total BAL cells | 71.4 ± 8.6 | 56.4 ± 3.8 | 51.5 ± 7.9 | 45.0 ± 6.1 | 171.6 ± 19.1*** | |
Mean ± SEM (× 103), an asterisk (*, **, and ***) denotes P < 0.05, ** P < 0.01, *** P < 0.001, using nonparametric two-way ANOVA with post-hoc Tukey-type multiple comparison test with time after exposure and dose as categorical variables.
Summary of Comet Assay Results from BAL Cells, Lung, and Liver Tissue 1, 3, and 28 Days Postexposure to Vehicle and NPCB (Vehicle Group n = 12, Particle Exposed Groups n = 8)
| Dose | Vehicle (H2O) | Printex 90 | ||||
|---|---|---|---|---|---|---|
| 0 µg | 0.67 µg | 2 µg | 6 µg | 162 µg | ||
| 1 Day | BAL TL | 14.3 ± 0.6 | 18.2 ± 1.4 | 16.9 ± 1.3 | 15.0 ± 0.9 | 15.3 ± 0.7 |
| BAL % TDNA | 4.6 ± 0.4 | 9.1 ± 0.9*** | 7.9 ± 0.7* | 7.0 ± 0.9 | 5.5 ± 0.2 | |
| Lung TL | 9.9 ± 0.4 | 9.3 ± 0.5 | 9.1 ± 0.4 | 8.9 ± 0.4 | 11.9 ± 0.6* | |
| Lung % TDNA | 4.3 ± 0.3 | 4.2 ± 0.5 | 4.3 ± 0.5 | 3.2 ± 0.2 | 7.9 ± 1.4** | |
| Liver TL | 16.3 ± 1.4 | 17.6 ± 1.3 | 17.9 ± 1.0 | 19.1 ± 0.6 | 16.8 ± 1.2 | |
| Liver % TDNA | 4.5 ± 0.5 | 5.5 ± 0.5 | 5.1 ± 0.5 | 5.3 ± 0.2 | 4.0 ± 0.3 | |
| 3 days | BAL TL | 12.7 ± 0.8 | 17.9 ± 1.3 | 18.6 ± 0.5** | 19.6 ± 0.7*** | 14.6 ± 1.6 |
| BAL % TDNA | 5.1 ± 0.4 | 7.3 ± 0.8 | 6.5 ± 0.7 | 6.1 ± 0.8 | 6.5 ± 0.6 | |
| Lung TL | 10.7 ± 0.6 | 9.5 ± 0.2 | 10.1 ± 0.2 | 8.8 ± 0.7 | 11.1 ± 0.5 | |
| Lung % TDNA | 2.1 ± 0.2 | 2.3 ± 0.4 | 2.5 ± 0.2 | 2.1 ± 0.5 | 2.5 ± 0.2 | |
| Liver TL | 18.2 ± 1.4 | 20.6 ± 1.5 | 16.3 ± 0.9 | 16.7 ± 0.8 | 17.7 ± 1.0 | |
| Liver % TDNA | 4.9 ± 0.5 | 6.5 ± 0.7 | 6.5 ± 0.5 | 5.7 ± 0.4 | 4.2 ± 0.5 | |
| 28 days | BAL TL | 13.9 ± 0.7 | 19.6 ± 0.9*** | 18.3 ± 1.2** | 15.7 ± 0.6 | 12.4 ± 0.6 |
| BAL % TDNA | 4.8 ± 0.5 | 6.1 ± 0.5 | 5.6 ± 0.7 | 5.7 ± 0.7 | 3.4 ± 0.2 | |
| Lung TL | 9.1 ± 0.4 | 7.8 ± 0.2 | 12.3 ± 0.5** | 11.0 ± 0.3** | 9.0 ± 0.3 | |
| Lung % TDNA | 2.0 ± 0.4 | 1.8 ± 0.2 | 3.3 ± 0.4** | 2.4 ± 0.3 | 2.0 ± 0.2 | |
| Liver TL | 18.4 ± 1.1 | 17.0 ± 0.7 | 17.8 ± 1.3 | 16.7 ± 1.0 | 18.4 ± 1.5 | |
| Liver % TDNA | 5.7 ± 0.6 | 4.1 ± 0.4* | 5.3 ± 0.4 | 4.4 ± 0.4* | 5.7 ± 0.7 | |
Mean ± SEM (× 103), an asterisk (*, **, and ***) denotes *P < 0.05, **P < 0.01, ***P < 0.001, using nonparametric two-way ANOVA with post-hoc Tukey-type multiple comparison test with time after exposure and dose as categorical variables).
Figure 2Correlation between TL and %TDNA in the comet assay.
Figure 3Pulmonary Saa3 mRNA expression level - dose response effect in mice 1, 3, and 28 days after intratracheal instillation of NPCB. The values represent mean of all animals in group ±SEM (n = 8–12). An asterisk (*) denotes P < 0.05, (***) P < 0.001, Saa3 mRNA expression levels in NPCB treated group versus vehicle controls.